What is the Jupiter Life Line Hospitals PE ratio today?
Jupiter Life Line Hospitals' PE ratio is 45.6 at the previous close (₹260.10 a share): a market capitalisation of ₹8,527 crore divided by consolidated net profit of ₹187 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹194 crore) it is 43.9.
What is the Jupiter Life Line Hospitals PB ratio (price to book value)?
Jupiter Life Line Hospitals' price-to-book (PB) ratio is 5.23 at the previous close: a market capitalisation of ₹8,527 crore divided by shareholders' equity (book value) of ₹1,630 crore on 30 September 2026. That is a book value of ₹49.73 per share against a share price of ₹260.10.
Is Jupiter Life Line Hospitals debt free?
No. Jupiter Life Line Hospitals had borrowings of ₹589 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.36. Its cash and current investments were ₹432 crore, so its net debt was ₹157 crore.
What is the Jupiter Life Line Hospitals market cap?
Jupiter Life Line Hospitals' market capitalisation was ₹8,527 crore at the previous close: 32.78 crore shares at ₹260.10 each.
What is the Jupiter Life Line Hospitals debt to equity ratio?
Jupiter Life Line Hospitals' debt-to-equity ratio was 0.36 on 30 September 2026: borrowings of ₹589 crore against total equity of ₹1,631 crore. A year earlier, on 30 September 2025, it was 0.23.
What is the Jupiter Life Line Hospitals book value per share?
Jupiter Life Line Hospitals' book value per share was ₹49.73 on 30 September 2026: shareholders' equity of ₹1,630 crore divided by the 32.78 crore shares in issue. The share price at the previous close was ₹260.10.
What is the Jupiter Life Line Hospitals net worth?
Jupiter Life Line Hospitals' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,630 crore on 30 September 2026, up 12.4% from ₹1,451 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,527 crore at the previous close.
What is the Jupiter Life Line Hospitals ROE and ROCE?
In FY26, Jupiter Life Line Hospitals' return on equity (ROE) was 13.4% and its return on capital employed (ROCE) was 13.1%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 15.3% and ROCE 16.4%.
What is the Jupiter Life Line Hospitals free cash flow?
In FY26, Jupiter Life Line Hospitals generated ₹268 crore of cash from operations and spent ₹502 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹234 crore. In FY25 it was −₹67.4 crore.
What is the Jupiter Life Line Hospitals EPS?
Jupiter Life Line Hospitals' basic earnings per share (EPS) were ₹29.59 in FY26, against ₹29.47 in FY25.
What is the Jupiter Life Line Hospitals dividend in 2026 and its record date?
In 2026, Jupiter Life Line Hospitals has declared one dividend: ₹1 (interim) with record date 22 May 2026.
What is the Jupiter Life Line Hospitals promoter holding?
Promoters held 40.91% of Jupiter Life Line Hospitals on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the Jupiter Life Line Hospitals shareholding pattern?
On 30 September 2026, Jupiter Life Line Hospitals' shares were held by promoters 40.91%, foreign portfolio investors (FII/FPI) 9.13%, domestic institutions (DII) 19.13% (including mutual funds at 13.45%) and retail and other non-institutional investors 30.83%. Over the year, FII holding was up 0.07 percentage points from 9.06% and DII holding was up 2.18 percentage points from 16.95%.
What is the Jupiter Life Line Hospitals revenue and profit in FY26?
In FY26 (April 2025–March 2026), Jupiter Life Line Hospitals' consolidated net profit was ₹194 crore, up 0.6% from ₹193 crore in FY25, on revenue from operations of ₹1,500 crore (up 18.9%). Over three years, from FY23, net profit was up 166.7%.
Jupiter Life Line Hospitals vs Apollo Hospitals Enterprise: how do they compare?
In FY26, Jupiter Life Line Hospitals earned net profit of ₹194 crore on revenue of ₹1,500 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Jupiter Life Line Hospitals' operating margin was 17.0% (Apollo Hospitals Enterprise 11.5%) and its return on equity 13.4% (Apollo Hospitals Enterprise 22.0%).
What are the Jupiter Life Line Hospitals latest quarterly results?
Jupiter Life Line Hospitals' latest results are for Q2 FY27 (July–September 2026): consolidated net profit ₹56.2 crore, down 2.1% from ₹57.4 crore in Q2 FY26; revenue from operations ₹456 crore, up 16.0% year on year.
When are the Jupiter Life Line Hospitals next results?
Jupiter Life Line Hospitals has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
How does Jupiter Life Line Hospitals compare with its peers?
On FY26 consolidated figures, against Apollo Hospitals Enterprise, Max Healthcare Institute and Krishna Institute of Medical Sciences: Jupiter Life Line Hospitals' operating margin of 17.0% is the second highest of the four (Apollo Hospitals Enterprise 11.5%, Max Healthcare Institute 21.5%, Krishna Institute of Medical Sciences 13.3%; peer average 15.4%); its return on equity of 13.4% is the third highest of the four (Apollo Hospitals Enterprise 22.0%, Max Healthcare Institute 14.3%, Krishna Institute of Medical Sciences 11.0%; peer average 15.8%); its revenue growth over three years of 18.9% a year is the third highest of the four (Apollo Hospitals Enterprise 14.9% a year, Max Healthcare Institute 22.4% a year, Krishna Institute of Medical Sciences 21.1% a year; peer average 19.5% a year).
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
